High Loss to Followup and Early Mortality Create Substantial Reduction in Patient Retention at Antiretroviral Treatment Program in North-West Ethiopia

Table 3

Kaplan-Meier estimate of mortality, loss to followup, and retention by baseline characteristics among AIDS patients on ART at University of Gondar Hospital ART program between March 2005 and August 2010.

Duration of followup	n	Mortality % (95% CI)	LTF % (95% CI)	Retention % (95% CI)
6 months	2479	3.7 (3.1–4.5)	9.0 (8.0–10.1)	87.5 (86.3–88.7)
12 months	2089	5.6 (4.8–6.6)	14.4 (13.1–15.8)	80.7 (79.2–82.1)
18 months	1734	7.1 (6.1–8.2)	17.7 (16.3–19.2)	76.4 (74.7–78.0)
24 months	1470	8.1 (7.0–9.3)	19.6 (18.1–21.2)	73.8 (72.1–75.5)
36 months	940	9.1 (7.9–10.4)	21.5 (19.9–23.3)	71.3 (69.4–73.0)
48 months	372	10.2 (8.8–11.6)	22.8 (21.1–24.7)	69.3 (67.2–71.2)
60 months	106	10.4 (9.0–12.1)	23.8 (21.9–25.9)	68.2 (66.0–70.3)
66 months	10	10.4 (9.0–12.1)	31.4 (19.5–48.1)	61.4 (47.3–72.7)